NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000687

Registered date:01/06/2007

A prospective Study of Treatment for Renal Anemia on Prognosis in Hemodialysis Patients

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPatients with renal anemia receiving erythropoietin, who have maintained dialysis therapy for over 1 year
Date of first enrollment2007/05/01
Target sample size500
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcome1) Doses of erythropoietin and iron requiring for the maintaince of Hb level>11 g/dl 2) Nutritional state 3) Cardiovascular event 4) Hospitaization 5) Survival rate
Secondary OutcomeThe relationships among Hb, ferritin level and markers of nutritional state (TP, albumin, pre-albumin, T-CHO, H-CHO, TG), and cardiovascular risk factors (MDA, MPO, Hs-CRP, TnT)

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients with malignancy, infection or inflammatory diseases.

Related Information

Contact

public contact
Name Takahiro Kuragano
Address 1-1 Mukogawa cho, Nishinomiya, Japan Japan
Telephone 0798-45-6521
E-mail kuragano@hyo-med.ac.jp
Affiliation Hyogo College of Medicine Internal Medicine Division of Nephrology and Dialysis
scientific contact
Name Takeshi Nakanishi
Address 1-1 Mukogawa cho, Nishinomiya, Japan Japan
Telephone 0798-45-6521
E-mail jin@hyo-med.ac.jp
Affiliation Hyogo College of Medicine Internal Medicine Division of Nephrology and Dialysis